There is a need for high quality applications to the European Union for funding to support research into liver disease. To encourage members to apply for these EU grants, EASL has set-up the EU Framework Programme Application Support Scheme.
EASL support is open to groups of individuals led by one or more EASL members who would like to apply for funding within one of the EU Framework Programme Calls. The EASL Governing Board selects a minimum of one application per year. The maximum grant awarded is €20,000 (€10,000 per stage of the EU application process, with second stage grants conditional of success at first stage of the application to the Commission).
In line with the Commission’s new two-stage Call submission process, this year EASL will provide support in two stages.
| Stage I applications | Applications for Stage I support should be received by EASL by 2nd August 2012 (for FP7-HEALTH-2013-Innovation-2) and 15th August 2012 (for FP 7–Health–2013-Innovation–1). |
| Initial applications should include: | |
|
|
|
|
|
|
| Stage II applications | Second stage applications for support should be sent to the EASL office by 14th January 2013”. |
The information provided at this second stage should include: |
|
|
|
|
|
i) Aims of the research project and its importance for human health or contribution to relevant areas of basic biomedical science ii) Why the group is well qualified to do this research and the added value in bringing together the constituent members iii) The proposed management structure and ownership of the work details of the general experimental approaches, study designs and techniques to be used iv) An outline of the scientific component of the final application and of the consortium structure |
FP7 applications should be sent to: margaret.walker@easloffice.eu
Visit the EASL newsroom for complementary information
Important :
EASL members who are scientific coordinators, or members of the steering committee, of a consortium interested in submitting an application to the EC in a topic related to research in liver disease are eligible to apply for EASL support.
Only one application per consortium is allowed.
Applications for EASL support are reviewed by the EASL Scientific Committee. The EASL Scientific Committee will take expert advice as required.
Successful applicants will be expected to report to EASL on the status of their EU application within 18 months of their initial application for EASL support.
For further information about EASL’s FP7 application support programme please contact Margaret Walker, Director of EU Public Affairs, at margaret.walker@easloffice.eu
